My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Xenon Pharmaceuticals Inc.

< Previous 1 2 Next >
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Reports Second Quarter 2025 Financial Results & Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Report Q2 2025 Financial Results on August 11, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Joins the Russell 3000® and Russell 2000® Indexes
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Report Q1 2025 Financial Results on May 12, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Present at Stifel 2025 Virtual CNS Forum
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Present at the 45th Annual TD Cowen Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Outlines Key Corporate Milestone Opportunities for 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Present at Upcoming Investor Conferences
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Reports Q3 2024 Financial Results and Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Report Q3 2024 Financial Results on November 12, 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.